![Mario Crovetto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mario Crovetto
Directeur/Membre du Conseil chez
ALIKO SCIENTIFIC S.A.
Profil
Mario P.
Crovetto is Director at Ikonisys SA since 2026 and a Member of the Supervisory Board at Curetis GmbH since 2021.
Former roles include Independent Director at OpGen, Inc. from 2020 to 2024, Chief Financial Officer at Eurand NV from 1999 to 2011, CFO and Vice President-Corporate Development at Recordati SpA from 1990 to 1999, and Independent Member of the Supervisory Board at Curetis NV from 2015 to 2020.
Education includes graduate studies at Harvard University and undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.
Postes actifs de Mario Crovetto
| Sociétés | Poste | Début |
|---|---|---|
| ALIKO SCIENTIFIC S.A. | Directeur/Membre du Conseil | 01/07/2021 |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Mario Crovetto
| Sociétés | Poste | Fin |
|---|---|---|
| CAPFORCE INC. | Directeur/Membre du Conseil | 25/03/2024 |
| CURETIS N.V. | Directeur/Membre du Conseil | 01/04/2020 |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Directeur Financier/CFO | 01/01/2011 |
| RECORDATI | Directeur Financier/CFO | 01/01/1999 |
Formation de Mario Crovetto
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
Eurand NV
Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recordati SpA
 Recordati SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Università Cattolica del Sacro Cuore Campus di Milano
 Università Cattolica del Sacro Cuore Campus di Milano Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Health Technology |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Develops miniaturized and integrated molecular diagnostic solutions | Health Services |
Ikonisys SA
 Ikonisys SA Medical SpecialtiesHealth Technology Manufactures and distributes cellular diagnosis applications for cancer, genetic diseases and fertility problems | Health Technology |
